
Validea's guru fundamental report indicates JOHNSON & JOHNSON (JNJ) receives an 87% rating based on their Multi-Factor Investor model, which is based on the strategy of Pim van Vliet and favors low volatility stocks with strong momentum and high net payout yields; this suggests the strategy has interest in the stock due to its underlying fundamentals and valuation.
Johnson & Johnson (JNJ) has received an 87% rating from Validea's Multi-Factor Investor model, a strategy developed by Pim van Vliet that prioritizes low volatility stocks also exhibiting strong momentum and high net payout yields. This score, above the 80% threshold typically indicating strategy interest, reflects positively on JNJ's underlying fundamentals and valuation as a large-cap growth stock within the Biotechnology & Drugs industry. The model specifically confirmed JNJ's suitability based on its market capitalization and standard deviation, resulting in a "PASS" for its final rank. However, the analysis also flagged "NEUTRAL" assessments for JNJ's "Twelve Minus One Momentum" and "Net Payout Yield," suggesting these specific factors are not primary drivers of the positive rating but do not significantly detract. The overall sentiment surrounding this assessment is strongly positive, with JNJ receiving a specific sentiment score of 0.8, underscoring the favorable view derived from this quantitative model which aligns with van Vliet's research into conservative factor investing.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.60
Ticker Sentiment